Roquette, a French multinational supplier of pharmaceutical and nutraceutical excipients, announced an investment by its venture capital arm Roquette Ventures in Danish start-up Biograil.
CordenPharma and pHLIP have announced their strategic alliance to collaborate in developing and commercializing the pHLIP-LNP targeted delivery platform for RNA-based and genetic therapeutics.
Invibio Material Solutions, the medical business of UK high-performance polymer producer Victrex, has opened a new product development facility in Leeds in order to accelerate commercialization of future applications.
The value in applying AI in Pharma is in making new and better drugs available faster than would be possible otherwise. By augmenting sparse-data AI with expert knowledge and applying it to the latest nanoparticle engineering techniques, opportunities are created to eliminate the risk associated with new techniques and give therapeutics a second chance to reach the patients who need them.
In 2019, the pharmaceutical industry invested $182 billion in drug development, but only 48 drugs were approved for use.
